November 19, 2026

BioPharmGuyNews.png

Move Your Regulatory Strategy Forward with Qosina


Qosina Regulatory Services helps medical device and pharmaceutical manufacturers navigate complex regulatory requirements with confidence. From quality management systems and audit preparation to regulatory strategy and submission support, our experts provide tailored guidance to help streamline processes and support compliance. Partner with Qosina to strengthen your regulatory approach and move your projects forward.


Visit https://bit.ly/3Vmfsw4 to learn more. 

BioPharmGuy

Went to an indie rock concert last night (Michigander) for the first time in about 15 years. Expected to be the oldest person in the place and I was not even close. The average age is much higher than it was back in the 2000s. Guess we all grew up together.


Email Outage

Wasn't last Thursday great timing for a Microsoft Outlook outage? I hope it didn’t interrupt your BioPharmGuy news reading too much. Hopefully today isn't Gmail's turn to be messed up due to something that is definitely not a cyber security incident.


(If it walks like a duck and quacks like a duck, sure it might be a CIA spy, but it's probably a duck.)


-BPG


Weekly BioPharmGuy Directory Edits

This week we added 31 companies and removed 34.


Best New Name:

Exolvo Biosciences


Worst New Name:

1nhaler


They Will Be Missed:

RAPT Therapeutics


Subscribe to our Weekly Update to have the full list of newly added companies sent directly to you each Thursday.

Industry

WTFunding

We know the levels of funding bandied about at major AI companies are insane, but rounds exceeding a billion are huge for biotech.


$5B, however, is absurd.


The hell does Isomorphic need all that loot for? We don't know.


But it seems many AI companies buy lab data, office data, operations, facilities data, basically all the data a biotech company has and they use these to better educate their LLMs on the whole life science business process and how it operates. They basically want to replicate how an entire company works.


While we have not been contacted by Isomorphic Labs, we have heard from other companies who are looking for data of this sort. If your company finds itself in need of funds, get in touch with us and we might be able to connect you.


Dominatio Liliorum

This week, as part of their industry takeover, Lilly invested in SRTD biotech, did a $5.9B deal with Stipple Bio and acquired Calytrix Bio for $1.5B.


To that we responded, 'Calytrix who'?


We never heard of them, and they don't even have a website. 


Is this all just a group of insiders buying their friends’ companies?


Evozyne

It's not colorful. It's not trendy. But it's a cool logo.


9/10


Team Roast - Shrinking

VeloGene's team is small, but there is a nice cascade from the top to the bottom.


The group starts with: Dr. Wu Guangming


Then the next person gets the same title but no given name: Dr. Zhao


Last guy, though, was more limited: Garland


Here's hoping they soon add: Z


Then: _


Then: .


Then a big finish with:


Looney 'toons

We can't be too sure what's going on at this website. But we can be sure they like Webtoons, since they put Webtoons on the menu.


Can't read a lick of Korean, so we can only wonder what about these webtoons are so cool they needed to be featured on a drug company website menu.


They Do Mean Everything

Sierra Sciences is one of the 'live forever' companies focusing on telomeres as their target of eternal life.


If you would like to learn everything there is to know about telomeres, no problem, they have you covered in the form of a TWO-HOUR video.


Damn, if you have that much time to waste on some guy's presentation, not much need for an extension, right?

Health & Science

State of the Prostate

The American Cancer Society has updated its prostate cancer screening recommendations for the first time since 2010. They now say men with average risk should be tested biannually from ages 50-69. Once they hit 70, it is murkier and after 75 they say fuhgeddaboudit since the costs may outweigh the benefits.


Good News, Bad News

Good News: the government negotiated the price of a lymphoma drug down from $193,000 to $43,000.


Bad news (for American patients): It was the Chinese government. Your price is still $500,000.


Measles

It’s again official – the US, along with Mexico and Bolivia has welcomed measles back after a 26-year hiatus.


It was never actually gone but was limited to such an extent it had been considered 'eradicated' in the US. Thanks to anti-vaxxers, not anymore! 


With the pace of culture change, maybe in 2040 it will be re-eliminated once these doofuses see more and more of the bad effects of measles.


Just in case you needed to be told, measles is TERRIBLE and has a 2-in-1000 chance of death.


B12. Hit.

Scientists have finally confirmed vitamin B12 is good for something, just not as a dietary supplement.


No, they have used it to make...batteries?


Hmm, in the US this slots in nicely on the battery spectrum. The original B battery is obsolete and has been for like 75 years, so now we could have AAAA, AAA, AA, B12, C & D.


But with our existing modern battery tech and infrastructure, does a vitamin battery matter?


Probably not, but that’s what science is about - you have no way of knowing what will matter until way down the line, so you discover stuff just for the sake of it.


That's the real danger in heavily restricting science funding or trying to force all researchers to work on things with economic implications. The biggest ideas could very easily never be investigated because people are stuck in the mindset of what is useful only at this very moment.


Light Day, Lame Night

A light day can refer to a lot of things – weightlifting, feminine hygiene and even space travel.


As far as space travel goes, the first human-created object passed the light day mark yesterday meaning Voyager 1 is now so far away it would take light an entire day to reach it. 


To commemorate this event, NASA suggested one of the dumber celebrations ever concocted and said people should shine their phones at the sky. 


Considering your phone has about a million times the capabilities of Voyager, it almost seems like a diss. Suck on this, Voyager!


But hey, If you did listen to NASA, we hope you had the maximum amount of fun possible while pointing your phone screen skyward in the dark.

Share!

Use this link to share on social platforms: View as Webpage


Subscribe!

If you haven't already, please join our mailing list.

BioPharmGuy is a registered trademark of Wilsonian LLC, Content © 2026 Wilsonian LLC